DNMT3A and acute myeloid leukemia: In addition, the frequency of DNMT3A mutations in the AML patients with the M5 subtype was higher compared with the patients of other subtypes, indicating that decreased DNMT3A expression caused by DNMT3A mutations may be associated with the incidence and progression of AML, particularly in the M5 subtype.